tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CGEM Stock Latest News

Cullinan Therapeutics price target raised to $33 from $28 at H.C. Wainwright
The FlyCullinan Therapeutics price target raised to $33 from $28 at H.C. Wainwright
23d ago
CGEM
Cullinan Management Achieves Milestone in Cancer Trial
PremiumCompany Announcements
Cullinan Management Achieves Milestone in Cancer Trial
23d ago
8K
CGEM
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
PremiumCompany Announcements
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
3M ago
CGEM
Cullinan Therapeutics to present preclinical data for CLN-978
PremiumThe Fly
Cullinan Therapeutics to present preclinical data for CLN-978
3M ago
CGEM
Cullinan Therapeutics reports Q3 EPS (69c), consensus (81c)
PremiumThe Fly
Cullinan Therapeutics reports Q3 EPS (69c), consensus (81c)
4M ago
CGEM
Cullinan Therapeutics sees cash runway into 2028
PremiumThe FlyCullinan Therapeutics sees cash runway into 2028
4M ago
CGEM
Cullinan Therapeutics to present preclinical data for CLN-978
Premium
The Fly
Cullinan Therapeutics to present preclinical data for CLN-978
4M ago
CGEM
Verizon downgraded, Canadian Pacific upgraded: Wall Street’s top analyst calls
Premium
The Fly
Verizon downgraded, Canadian Pacific upgraded: Wall Street’s top analyst calls
4M ago
CP
RF
Cullinan Therapeutics initiated with a Buy at UBS
PremiumThe Fly
Cullinan Therapeutics initiated with a Buy at UBS
4M ago
CGEM
Cullinan Management Advances SLE Treatment with FDA Trial
PremiumCompany Announcements
Cullinan Management Advances SLE Treatment with FDA Trial
4M ago
8K
CGEM
Cullinan receives U.S. FDA clearance for IND application for CLN-978
PremiumThe Fly
Cullinan receives U.S. FDA clearance for IND application for CLN-978
4M ago
CGEM
Cullinan Management Advances SLE Treatment with CLN-978 Trial
PremiumCompany Announcements
Cullinan Management Advances SLE Treatment with CLN-978 Trial
5M ago
8K
CGEM
3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts 
5M ago
BMRN
CGEM
Cullinan Therapeutics receives approval to initiate Phase 1 trial of CLN-978
Premium
The Fly
Cullinan Therapeutics receives approval to initiate Phase 1 trial of CLN-978
5M ago
CGEM
Cullinan Therapeutics submits IND application to FDA for CLN-978
Premium
The Fly
Cullinan Therapeutics submits IND application to FDA for CLN-978
5M ago
CGEM
Cullinan presents data from Module C of Zipalertinib pivotal Phase 2b study
PremiumThe Fly
Cullinan presents data from Module C of Zipalertinib pivotal Phase 2b study
5M ago
CGEM
Cullinan Therapeutics sees cash runway into 2028
PremiumThe Fly
Cullinan Therapeutics sees cash runway into 2028
7M ago
CGEM
Cullinan Therapeutics reports Q2 EPS (75c), consensus (73c)
PremiumThe Fly
Cullinan Therapeutics reports Q2 EPS (75c), consensus (73c)
7M ago
CGEM
Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise
PremiumCompany Announcements
Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise
9M ago
8K
CGEM
Cullinan announces initial data from pivotal Phase 2b REZILIENT1 study
PremiumThe FlyCullinan announces initial data from pivotal Phase 2b REZILIENT1 study
9M ago
CGEM
Cullinan Therapeutics to present first data for CLN-619 at ASCO
Premium
The Fly
Cullinan Therapeutics to present first data for CLN-619 at ASCO
9M ago
CGEM
Cullinan Therapeutics files to sell 14.4M shares of common stock for holders
Premium
The Fly
Cullinan Therapeutics files to sell 14.4M shares of common stock for holders
9M ago
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >